Literature DB >> 17484896

Ribavirin: is it a mutagen for hepatitis C virus?

Alan S Perelson, Thomas J Layden.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17484896     DOI： 10.1053/j.gastro.2007.03.077

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  11 in total

1.  Ribavirin can be mutagenic for arenaviruses.

Authors:  Héctor Moreno; Isabel Gallego; Noemí Sevilla; Juan Carlos de la Torre; Esteban Domingo; Verónica Martín
Journal:  J Virol       Date:  2011-05-11       Impact factor: 5.103

2.  Structure of foot-and-mouth disease virus mutant polymerases with reduced sensitivity to ribavirin.

Authors:  Cristina Ferrer-Orta; Macarena Sierra; Rubén Agudo; Ignacio de la Higuera; Armando Arias; Rosa Pérez-Luque; Cristina Escarmís; Esteban Domingo; Nuria Verdaguer
Journal:  J Virol       Date:  2010-04-14       Impact factor: 5.103

Review 3.  Treatment of hepatitis C virus infection with interferon and small molecule direct antivirals: viral kinetics and modeling.

Authors:  Libin Rong; Alan S Perelson
Journal:  Crit Rev Immunol       Date:  2010       Impact factor: 2.214

4.  Evidence for action of ribavirin through the hepatitis C virus RNA polymerase.

Authors:  N A Cannon; M J Donlin; L M Mayes; A C Lyra; A M Di Bisceglie; J E Tavis
Journal:  J Viral Hepat       Date:  2009-02-23       Impact factor: 3.728

5.  Therapeutically targeting RNA viruses via lethal mutagenesis.

Authors:  Jason D Graci; Craig E Cameron
Journal:  Future Virol       Date:  2008-11       Impact factor: 1.831

6.  A multi-step process of viral adaptation to a mutagenic nucleoside analogue by modulation of transition types leads to extinction-escape.

Authors:  Rubén Agudo; Cristina Ferrer-Orta; Armando Arias; Ignacio de la Higuera; Celia Perales; Rosa Pérez-Luque; Nuria Verdaguer; Esteban Domingo
Journal:  PLoS Pathog       Date:  2010-08-26       Impact factor: 6.823

7.  Favipiravir elicits antiviral mutagenesis during virus replication in vivo.

Authors:  Armando Arias; Lucy Thorne; Ian Goodfellow
Journal:  Elife       Date:  2014-10-21       Impact factor: 8.140

8.  Potential benefits of sequential inhibitor-mutagen treatments of RNA virus infections.

Authors:  Celia Perales; Rubén Agudo; Hector Tejero; Susanna C Manrubia; Esteban Domingo
Journal:  PLoS Pathog       Date:  2009-11-13       Impact factor: 6.823

9.  Counteracting quasispecies adaptability: extinction of a ribavirin-resistant virus mutant by an alternative mutagenic treatment.

Authors:  Celia Perales; Rubén Agudo; Esteban Domingo
Journal:  PLoS One       Date:  2009-05-14       Impact factor: 3.240

10.  Extinction of hepatitis C virus by ribavirin in hepatoma cells involves lethal mutagenesis.

Authors:  Ana M Ortega-Prieto; Julie Sheldon; Ana Grande-Pérez; Héctor Tejero; Josep Gregori; Josep Quer; Juan I Esteban; Esteban Domingo; Celia Perales
Journal:  PLoS One       Date:  2013-08-16       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.